These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29121750)

  • 1. Novel ECG parameters are strongly associated with inflammatory
    Sipilä K; Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K
    Int J Cardiol; 2017 Dec; 249():454-460. PubMed ID: 29121750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
    Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Tuominen H; Haarala A; Tikkakoski A; Korkola P; Kähönen M; Nikus K; Sipilä K
    J Nucl Cardiol; 2019 Apr; 26(2):394-400. PubMed ID: 28585031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events.
    Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K; Sipilä K
    J Nucl Cardiol; 2021 Feb; 28(1):199-205. PubMed ID: 30815833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
    Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
    Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
    J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
    Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
    J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.
    Ishimaru S; Tsujino I; Takei T; Tsukamoto E; Sakaue S; Kamigaki M; Ito N; Ohira H; Ikeda D; Tamaki N; Nishimura M
    Eur Heart J; 2005 Aug; 26(15):1538-43. PubMed ID: 15809286
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Omote K; Naya M; Koyanagawa K; Aikawa T; Manabe O; Nagai T; Kamiya K; Kato Y; Komoriyama H; Kuzume M; Tamaki N; Anzai T
    J Nucl Cardiol; 2020 Dec; 27(6):2135-2143. PubMed ID: 30610523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis.
    Terasaki F; Fujita SI; Kanzaki Y; Hirose Y; Ishizaka N
    Int Heart J; 2018 May; 59(3):647-651. PubMed ID: 29681578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
    Yamagishi H; Shirai N; Takagi M; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
    J Nucl Med; 2003 Jul; 44(7):1030-6. PubMed ID: 12843216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes.
    Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K; Sipilä K
    J Nucl Cardiol; 2020 Feb; 27(1):109-117. PubMed ID: 29721764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
    Manabe O; Yoshinaga K; Ohira H; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Masuda A; Magota K; Nishimura M; Tamaki N
    Ann Nucl Med; 2014 Aug; 28(7):656-63. PubMed ID: 24889126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter- and Intraobserver Agreement of
    Ohira H; Ardle BM; deKemp RA; Nery P; Juneau D; Renaud JM; Klein R; Clarkin O; MacDonald K; Leung E; Nair G; Beanlands R; Birnie D
    J Nucl Med; 2017 Aug; 58(8):1324-1329. PubMed ID: 28254873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
    Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
    Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
    Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging.
    Bravo PE; Raghu G; Rosenthal DG; Elman S; Petek BJ; Soine LA; Maki JH; Branch KR; Masri SC; Patton KK; Caldwell JH; Krieger EV
    Int J Cardiol; 2017 Aug; 241():457-462. PubMed ID: 28318664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.